| Drug Name |
Liothyronine |
| Drug ID |
BADD_D01296 |
| Description |
Liothyronine is a thyroidal hormone T3 which is normally produced by the thyroid gland in a ratio 4:1 when compared with T4: T3. Liothyronine is the active form of thyroxine which is composed in a basic chemical structure by a tyrosine with bound iodine.[T457] The exogenous liothyronine product was developed by King Pharmaceuticals and FDA approved in 1956.[L5578] |
| Indications and Usage |
Used as replacement or supplemental therapy in patients with hypothyroidism of any etiology, except transient hypothyrodism during the recovery phase of subacute thyroiditis. |
| Marketing Status |
Prescription |
| ATC Code |
H03AA02 |
| DrugBank ID |
DB00279
|
| KEGG ID |
D01011
|
| MeSH ID |
D014284
|
| PubChem ID |
5920
|
| TTD Drug ID |
D0S6JG
|
| NDC Product Code |
Not Available |
| Synonyms |
Triiodothyronine | T3 Thyroid Hormone | Thyroid Hormone, T3 | Liothyronine | 3,3',5-Triiodothyronine | Liothyronine Sodium | Cytomel |
